The QualityStocks Daily Thursday, October 25th, 2018

Today's Top 3 StockMarketWatch

StocksToBuyNow (TVTV) +65.23%

StockMarketWatch (AMRH) +18.79%

NetworkNewsWire (CSRH) +16.67%

The QualityStocks Daily Stock List

Data Storage Corp. (DTST)

RockingPennyStocks, Buzz Stocks, Stock Guru, Planet Penny Stocks, PennyStocks24, PricelessPennyStocks, Stock Twiter, SecretStockPromo, Stock Onion, EpicVIP Group, Real Pennies, Epic Stock Picks, Wolf of Penny Stocks, ActualGains, PennyStockRumors, Penny Pick Finders, Penny Picks, PennyStockProphet, Bull Trends, Information Solutions Group, StockMister, Penny Dreamers, AlphaPennyStock, Investor News Source, and TopPennyStockMovers reported earlier on Data Storage Corp. (DTST), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Data Storage has acquired ABC Services and ABC Services II, a 25-year provider of IBM equipment, IAAS, managed and professional services, including the remaining 50 percent ownership of Secure Infrastructure and Services. With the acquisition, Data Storage expands its present solutions.

Data Storage Corp. provides cloud-based technology solutions. The Company provides hardware, software-as-a-service (SaaS), managed IT (Information Technology) services, installation, and maintenance, centered on compliance, message archiving, analytics, disaster recovery, and business continuity. Message Logic is a business unit of the Company. Data Storage has its corporate office in Garden City, New York. A Cloud Services Provider, the Company lists on the OTC Markets Group’s OTCQB.

Data Storage provides its solutions and services through taking advantage of leading technologies. These include virtualization, cloud computing, and cloud storage. The Company formed Nexxis, Inc. This subsidiary concentrates on the development of next-generation voice and data services intended to help companies speed up their communications, boost revenue, as well as reduce costs.

Data Storage’s solutions include offsite data protection and recovery services, High Availability (HA) replication services, email compliance solutions for e-discovery, continuous data protection, data de-duplication, virtualized system recovery, and telecommunications recovery services. Its Message Logic business unit delivers regulatory compliant email archiving and analytics to enterprises around the world.

Message Logic’s MLArchiver provides a solution uniting archiving, records management, eDiscovery, and analytics to deliver a new level of advanced capabilities. In addition, the Company’s Secure Infrastructure & Services focuses on providing infrastructure as a service (IAAS). It specializes in power systems, iseries and AS400 users.

Data Storage has its partnership with TierPoint.  TierPoint’s data centers provide efficient power, connectivity, the Internet and an assortment of additional services. This allows Data Storage to deliver specialized services and applications to its clients.

In September, Data Storage announced the release of its newest solution, the IBM Power Monitor 24, a Pro-Active IBM i systems monitoring service. The worldwide accessible service provides clients who use IBM power servers total confidence in knowing their business systems are being automatically monitored by the solution. This includes 24/7 support by its certified technical staff.

The critical service runs nonstop, checking the health of systems, enabling the DSC technical staff to help in any areas requiring improvement for the system’s reliability and performance.  The cost-effective, high value service ensures IBM i system issues are addressed in a timely manner, lessening the impact and disruption to the business.

Data Storage Corp. (DTST), closed Thursday's trading session at $0.189, up 5.00%, on 500 volume with 2 trades. The average volume for the last 3 months is 39,493 and the stock's 52-week low/high is $0.068/$1.00.


ProtoKinetix, Inc. (PKTX)

Willy Wizard, 777 Stocks, Breaking Bulls, InsideBulls, SmallCapVoice, OTCReporter, Stock Rich, PennyStockAce, Stockpalooza, SuperBirdStocks, WallStAlerts, Stock Market News Alert, Pick Alerts, Penny stock Profitz, AllPennyStocks, Penny Invest, CoolPennyStocks, TopPennyStockMovers, HotOTC, StockEgg, and Round Up the Bulls reported previously on ProtoKinetix, Inc. (PKTX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Inc. is a molecular biotechnology company based in Marietta, Ohio. The Company has developed and patented a family of hyper stable, potent glycopeptides (Anti-Aging GlycoPeptide - AAGP™) that enhance engraftment and protection of transplanted cells utilized in regenerative medicine. ProtoKinetix lists on the OTC Markets Group’s OTCQB.

Due to the anti-inflammatory effect of AAGP™ molecules, ProtoKinetix is now targeting the direct treatment of diseases that have a major inflammatory component. The Company’s, AAGP™, is an antifreeze glycopeptide. It imitates a naturally occurring glycoprotein found in Arctic fish. Its AAGP™ molecule is helping to substantially improve the efficacy of Cell Transplant Treatments for diabetes. ProtoKinetix has extensive patent protection for its portfolio of anti-aging glycopeptides.

The Company’s anti-aging glycopeptide is trademarked AAGP™. This is a small (580.96 Daltons), stable, synthetic replica of the larger (>2,600 Daltons), less stable AFGP, which has been found to have protective properties in nature. The small size of AAGP™ enables it to penetrate cells. It permits it to pass through cell and capillary junctions in vivo.

Moreover, its bioactivity at a range of pHs (5.3-10.3) and temperatures (-196°C to 22°C) and efficiency at concentrations (1mg/ml) is well below its toxic dose (50mg/ml). This makes it a candidate to enter the next stages of translational research.

Recently, ProtoKinetix announced that it executed a Material Transfer Agreement (MTA) with a reputed biotechnology company having a number of worldwide offices on four continents. Under the MTA, ProtoKinetix and this company are working together to test the effects AAGP® have on three projects. One project is Cryopreservation of Primary Mammalian Tissue Cells. A second project is Enhancing the Viability of Primary Mammalian Cells. The third project is Cell Lines Under Stressed Culture Conditions.

In September, ProtoKinetix announced the launch of a proof of concept study in the field of cardiovascular sciences. Dr. Thomas Pulinilkunnil, Associate Professor, Department of Biochemistry and Molecular Biology, Dalhousie University is the main investigator on the project. Pulinilkunnil laboratory will screen and examine the therapeutic utility of PKX-001 (AAGP®) against inflammatory, hypertrophic, and also ischemic pathologies in the heart.

ProtoKinetix, Inc. (PKTX), closed Thursday's trading session at $0.0801, up 0.12%, on 14,870 volume with 4 trades. The average volume for the last 3 months is 72,750 and the stock's 52-week low/high is $0.03/$0.129.


Timberline Resources Corp. (TLRS)

Zacks, MarketWatch, Amigo Bulls, InvestorsHub, Real Investment Advice, Market Screener, Marketbeat, and Gold Investment Letter reported earlier on Timberline Resources Corp. (TLRS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Timberline Resources Corp. is a gold exploration and development company. Its operational focus is the State of Nevada. The Company’s flagship Talapoosa Project is a partially permitted, open-pit, heap leach gold project with low capital and operating costs and robust economics. Additionally, its exploration efforts have been focused on its 23 square-mile Eureka land package. This is one of the largest remaining undeveloped gold properties in Nevada. Timberline Resources is headquartered in Coeur d’Alene, Idaho.

The Company is refocusing its exploration efforts on advancing the Windfall and Lookout Mountain projects at its Eureka property. This is simultaneous with relinquishing its option to acquire the Talapoosa project. Regarding the Eureka land package, it includes Timberline’s Lookout Mountain project and a pipeline of earlier-stage projects that feature past gold production, historic gold estimates, and/or drill-indicated gold mineralization. Eureka is on the south end of Nevada’s Battle Mountain/Eureka Trend.

Timberline Resources continues to advance its Lookout Mountain and Windfall project areas at Eureka. The Company purchased a large block of patented and unpatented mining claims in 2012. These comprise primarily the entire Seven Troughs gold mining district near Lovelock in Pershing County, Nevada. The purchased property package covers 4,100 acres. It consists of 64 patented and 238 unpatented lode mining claims, all which are under a long-term lease agreement, along with 162 additional unpatented lode mining claims.

Timberline Resources announced this past August that it closed on the acquisition of ownership interests in two Nevada gold-copper mineral properties in the Battle Mountain mining district in Nevada from Americas Gold Exploration, Inc. (AGEI). This acquisition includes the right to earn into existing Joint Venture agreements with McEwen Mining, Inc. at the Elder Creek Project (Elder Creek Joint Venture), and with Lac Minerals (USA) LLC, a wholly-owned subsidiary of Barrick Gold Corporation (LAC) at the Paiute Project (Paiute Joint Venture).

Earlier this month, Timberline Resources announced that a detailed gravity survey and analysis of historic geophysical survey data identified untested targets for high-grade, ''Carlin-style'' gold mineralization at the Lookout Mountain Project within its 23-square mile (60 km2) Eureka property. The gravity, CSAMT, induced polarization (IP), and magnetic data show distinct geophysical signatures over earlier identified high-grade gold mineralization on the property. These geophysical signatures were subsequently used to identify possible extensions of the mineralized zones and new targets for drilling.

Last week, Timberline Resources provided an update on drilling at the Elder Creek porphyry copper-gold project in the Battle Mountain Mining District of Nevada. The drilling program started in mid-September and is now finished.

Mr. Steven Osterberg, Timberline Resources’ President and Chief Executive Officer, said, "We are impressed with several hundred feet of drill core exhibiting extensive stock-work veining, intense mineral alteration, and visible iron, copper, and molybdenum sulfide mineralization. The drilling, combined with surface mapping and geophysical surveys, confirms that Elder Creek is a very large mineralized porphyry system. We look forward to the analytical results and additional drill testing."

Timberline Resources Corp. (TLRS), closed Thursday's trading session at $0.0941, up 10.71%, on 179,414 volume with 17 trades. The average volume for the last 3 months is 64,230 and the stock's 52-week low/high is $0.00009/$0.3184.


Investview, Inc. (INVU)

StockDeputy, Stockflare, Investopedia, Stockhouse, MarketWatch, Barchart, InvestorsHub, Marketwired, OTC Markets, and TradingView reported on Investview, Inc. (INVU), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Investview, Inc. is a diversified financial technology company listed on the OTCQB. It operates mainly through its wholly- and majority-owned subsidiaries. Investview provides financial products and services to accredited investors, self-directed investors, as well as select financial institutions. The Company has its Wealth Generators wholly-owned subsidiary recently undergoing a name change. Investview has its corporate headquarters in Salt Lake City, Utah.

Fundamentally, Investview provides education and technology designed to help individuals in navigating the financial markets. The Company’s services include tools and research, newsletter alerts, and live education rooms, which consist of instruction on the subjects of equities, options, FOREX, ETF’s, and binary options. Furthermore, Investview offers education and technology applications to help individuals in debt reduction, enhanced savings, budgeting, and proper tax expense management. The Company has added Crypto mining services and education to its program services.

Wealth Generators’ products are provided to individuals on a monthly subscription basis. Wealth Generators is classified as a publisher of financial research and information and it is exempt from securities registration. Wealth Generators provides financial technology, education, and research to individuals. It is not a brokerage firm or Registered Investment Advisor. It does not execute trades or take possession of clients' brokerage accounts. Wealth Generators’ products undergo distribution via a direct sales model.

Investview announced this past March that it filed a name change for its wholly-owned subsidiary Wealth Generators LLC to Kuvera LLC.  Investview changed the name of Wealth Generators to Kuvera LLC in its first steps to create its vision for its recently acquired LLC. Investview released the Kuvera brand in the final transition steps to rename its wholly-owned subsidiary Wealth Generators LLC to Kuvera LLC. Investview completed the transition April 12, 2018 when it unveiled the Kuvera brand via a series of live launch webinars, the release of and a total set of marketing tools to share the Kuvera vision and mission.

Investview has entered into an agreement with BYOBitcoin LLC. This agreement is to provide mining hardware, software and services for Bitcoin mining. Investview’s ability to provide a turn-key hardware and services package allows individuals to participate in what has become a technology sector mainly controlled by large players who can establish massive mining farms.

Mr. Ryan Smith, Chief Executive Officer, said, ''We have received numerous requests for Bitcoin mining since our initial mining launch. Our agreement with BYOBitcoin provides the necessary expertise and large-scale Bitcoin mining operations our customers desire.''

Investview, Inc. (INVU), closed Thursday's trading session at $0.02, up 6.38%, on 25,577 volume with 5 trades. The average volume for the last 3 months is 185,780 and the stock's 52-week low/high is $0.0072/$0.10.


Workhorse Group, Inc. (WKHS)

Stocktwits, MarketWatch, Morningstar, The Street, CapitalCube, GuruFocus, Simply Wall St, InvestorsHub, 4-Traders, Stockhouse, Equity Clock,, Zacks, Investopedia, Last10K, Business Insider, and StreetInsider reported on Workhorse Group, Inc. (WKHS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Workhorse Group, Inc. is a technology company centered on providing sustainable and cost-effective electric mobility solutions to the commercial electric transportation sector. An American original equipment manufacturer (OEM), the Company designs and builds high performance battery-electric vehicles including trucks and aircraft. Workhorse Group is headquartered in Loveland, Ohio. The Company’s shares trade on the NasdaqCM.

Moreover, Workhorse Group develops cloud-based, real-time telematics performance monitoring systems. These systems are completely integrated with the Company’s vehicles. They enable fleet operators to optimize energy and route efficiency.

The design of all Workhorse vehicles is to make the movement of people and goods more efficient and less harmful to the environment. Workhorse Group is a foremost manufacturer of medium-duty electric step vans in the United States targeting commercial fleets. The Company is the only OEM building electrified medium-duty vehicles in the U.S.

Workhorse Group is developing the Workhorse W-15, the U.S.’ first light-duty pickup truck with electric powertrain aimed at commercial fleets. Target customers include delivery fleets, utility companies, telecommunications companies, municipalities and more.

The Company designs and produces battery-electric power trains in its 50,000 sq. ft. facility in Loveland for its new Workhorse chassis. Its approach to building its battery electric power trains uses proven, automotive-grade, mass-produced parts together with its custom designed, proprietary control software.

Workhorse Group has its N-GEN Electric Delivery Van; the W-15 electric pickup truck with extended range; the E-Gen Step Van; the SureFly™ Helicopter; the HorseFly™ Autonomous Drone Delivery System; and the METRON™ Telematics and Asset Tracking Software.

At the beginning of May, Dana Incorporated (DAN) and Workhorse Group announced the design, development, and production of a city delivery vehicle featuring Dana's Spicer® Electrified™ integrated e-Drive axle. Expanding the established Spicer Electrified portfolio, the new integrated e-Drive axle is ideal for the Workhorse vehicle.

It delivers considerable efficiency for its city delivery duty cycle. It does so while offering a major weight savings of 388 pounds, permitting higher payload and battery capacity. Dana is an international leader in highly engineered solutions for improving the efficiency, performance, as well as sustainability of powered vehicles and machinery.

For Q1 2018, Workhorse Group announced an expanded partnership with UPS for up to 1000 N-GEN electric delivery vans. In addition, the Company deployed the first N-GEN production intent vehicle executing live deliveries in the San Francisco Bay Area. Moreover, it received a patent for the HorseFly™ truck-launched drone delivery system from the United States Patent and Trademark Office (USPTO).

Furthermore, Workhorse Group initiated a change-over to a production facility in preparation for assembly of N-GEN and W-15 platforms, boosting line capacity to 30 units per day.

Yesterday, Workhorse Group announced that the HorseFly truck-launched Autonomous Drone Package Delivery System is now making real-life package deliveries to homes in the Cincinnati area in a pilot program with the City of Loveland and the FAA (Federal Aviation Administration). Consumers in select Cincinnati zip codes chose to accept packages from Horsefly through the Workhorse Ares Drone Package Delivery App.

The design of this APP is to seamlessly integrate with existing online e-commerce platforms. The HorseFly UAV Delivery System is a custom-built, high efficiency delivery UAV. It is completely integrated with the Workhorse line of electric delivery trucks.

Mr. Steve Burns, Chief Executive Officer of Workhorse Group, said, "We feel this is a game-changing moment to innovate the way packages are delivered for many years to come. By not only reducing the expense of last mile delivery, but also providing the consumer with the ability to opt-in, visualize, and confirm their package delivery on their property, we have re-imagined home delivery."

Workhorse Group, Inc. (WKHS), closed Thursday's trading session at $0.8571, up 3.25%, on 279,012 volume with 681 trades. The average volume for the last 3 months is 270,332 and the stock's 52-week low/high is $0.80/$3.45.


Vitality Biopharma, Inc. (VBIO)

Stock Beast, SmallCap Network, and Promotion Stock Secrets reported previously on Vitality Biopharma, Inc. (VBIO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Vitality Biopharma, Inc.’s commitment is to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Since 2012, it has developed a unique capability to produce molecules by way of glycosylation, a form of enzymatic biosynthesis that was originally developed to improve the taste of stevia. The platform is well suited for the discovery of new pharmaceutical products. Vitality Biopharma is based in Los Angeles, California.

The Company successfully modified cannabidiol (CBD) late in 2015, which is not psychoactive. In ongoing work it has created a novel class of pharmaceuticals called cannabosides. Cannabosides, upon ingestion, can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract.

Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits. This is while lessening or avoiding the systemic delivery of THC into the bloodstream.

Vitality Biopharma can biosynthesize cannabinoid glycosides (cannabosides) through enzyme biosynthesis. The Company is one of only a very few groups globally who know how to produce and work with the enzymes that perform glycosylation. It has been centered on it because the same enzymes are used to modify the taste of stevia (steviol glycosides).

In October of 2017, Vitality Biopharma announced the achievement of a biosynthesis breakthrough. It developed a proprietary biosynthesis technology, which can modify cannabinoids to create pharmaceutical prodrugs that have no psychoactivity and that can provide targeted disease treatment. The process involves small molecule glycosylation, where sugar molecules are attached to cannabinoids, creating new compounds called cannabinoid glycosides, or cannabosides.

Vitality Biopharma has introduced its lead cannabinoid drug formulation VITA-100 as a non-psychoactive prodrug of THC. It is focusing initial clinical development efforts on VITA-100, a proprietary THC cannabinoid drug formulation. The Company’s plan is to complete a first-in-man clinical study in the first half of 2018.

The treatment indications it plans to evaluate in Phase 2 trials include inflammatory bowel disease (IBD), irritable bowel syndrome, and narcotic bowel syndrome (a severe form of opiate-induced abdominal pain). Last month, Vitality Biopharma announced the pending establishment of a wholly-owned Canadian subsidiary, Vitality Genetics, Ltd. This subsidiary will concentrate on and enable the performance of a broad array of cannabinoid genetics research and development programs.

Vitality Biopharma is now planning limited operations in Canada. This is to benefit from Health Canada regulations concerning medical cannabis and the federal commitment to nationwide approval for adult use of cannabis.

This month, Vitality Biopharma announced the discovery of new antimicrobial activity of cannabinoids and its application for treatment of C. difficile-associated diarrhea and colitis. In experiments executed according to guidance by the Clinical Laboratory and Standards Institute (CLSI), the Company determined that cannabinoids (including THC) are effective antibiotics for C. diff, VRE, and an assortment of additional pathogens.

Vitality Biopharma filed a non-provisional international patent application on May 9, 2018, pursuant to the Patent Cooperation Treaty (Appl. No. PCT/US2018/031727) titled “Antimicrobial Compositions Comprising Cannabinoids and Methods of Using the Same.”

Vitality Biopharma, Inc. (VBIO), closed Thursday's trading session at $1.685, up 3.37%, on 239,842 volume with 297 trades. The average volume for the last 3 months is 211,852 and the stock's 52-week low/high is $1.05/$2.37.


Freedom Leaf, Inc. (FRLF)

Promotion Stock Secrets, CFN Media Group, SmallCapVoice, and StocksToBuyNow reported on Freedom Leaf, Inc. (FRLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a group of global, vertically integrated hemp businesses and cannabis media companies. It is a foremost go-to resource in the cannabis, medical marijuana, and industrial hemp industry. Freedom Leaf is building a varied portfolio of valuable businesses via strategic mergers, acquisitions, and acceleration projects across the industry. Freedom Leaf is based in Las Vegas, Nevada. Leafceuticals, Inc. is a wholly-owned division of Freedom Leaf.

The Company engages in mergers and acquisitions (M&A’s) in the marijuana industry. This includes incubation/acceleration and spin offs of new marijuana/hemp related companies. Freedom Leaf does not handle, grow, sell, or disperse marijuana.

Freedom Leaf targets acquisitions of high growth and niche companies. Its strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development.

The Company’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-developing and changing cannabis, medical marijuana, and industrial hemp industry. The content Freedom Leaf produces and curates principally attracts industry professionals.

Freedom Leaf earlier acquired This is the Spanish Speaking community's leading cannabis website. As part of this acquisition, Freedom Leaf acquired This is the largest Medical Cannabis information website in Spanish.

Hempology® is Freedom Leaf’s exclusively branded product line. Hempology® is now vertically integrated from seed to consumer, processing CBD and a complete spectrum of whole-hemp extracts for the entourage-effect. In addition, Freedom Leaf has its hemp-based rolling paper company, Plants to Paper.

This past January, Freedom Leaf reported that it fully acquired 100 percent of Green Market Europe S.L. (GME). GME is a Spanish producer of hemp products. Its facilities include a 21,000 sq. ft. light deprivation greenhouse, a 43,000 sq. ft. indoor growing research facility, and greater than 200 acres of outdoor production space.

In April, Freedom Leaf announced that it consummated its earlier-announced acquisition of the Irie CBD Product Line. This includes virtually all assets, trademarks, formulating equipment, formulas and products. Irie is a California-based CBD, "Cannabidiol", product line. It formulates, manufactures and distributes CBD tinctures, CBD edibles, CBD topicals and CBD concentrates to retail markets throughout the nation.

Today, Freedom Leaf announced it purchased a 25 percent equity interest in Cicero Transact, an invitation-only online community committed to building strategic business alliances and a solid method of transacting business. Cicero Transact is a new, exclusive platform. It brings together start-ups, entrepreneurs, companies, venture capital, and private equity firms to facilitate joint ventures (JVs), strategic partnerships, product and service transactions, mergers and acquisitions (M&As).

Freedom Leaf’s intention is to work with Cicero Transact concerning deals related to the cannabis and industrial hemp industry and other areas that can boost revenue. A soft launch of the Cicero Platform will take place in August of this year with a full launch soon after.

Freedom Leaf, Inc. (FRLF), closed Thursday's trading session at $0.3024, up 1.86%, on 3,655,953 volume with 592 trades. The average volume for the last 3 months is 1,760,008 and the stock's 52-week low/high is $0.0265/$0.795.


Exicure, Inc. (XCUR)

Penny Stock Hub, Street Insider, MarketWatch, Business Wire, Stockopedia, 4-Traders, Stockwatch, Simply Wall St, TradingView, AdisInsight, InvestorsHangout, Insider Monkey, BioPortfolio, OTC Markets, WalletInvestor, OpenInsider, InsiderMole, and Interactive Brokers reported on Exicure, Inc. (XCUR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Exicure, Inc. is a clinical stage biotechnology company listed on the OTC Markets’ OTCQB. The Company is developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's lead programs focus on oncology, inflammatory diseases, and genetic disorders. Exicure has its corporate office in Chicago, Illinois.

The Company's intellectual property (IP) portfolio includes over 140 pending patent applications and greater than 55 allowed or issued patents. These filings cover a range of inventions, including fundamental nanoparticle manufacturing breakthroughs and manifold application-specific improvements.

Regarding Partnering and Licensing, Exicure's strategy is to maximize the potential of its Spherical Nucleic Acid (SNA) technology platform through in-house development, collaborations, and licensing. In addition, the Company may establish platform partnerships with pharmaceutical companies across numerous indications or within specific therapeutic areas.

Exicure's proprietary 3-dimensional, Spherical Nucleic Acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a broad array of cells and tissues. SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics - the safe and effective delivery into cells and tissues.

Exicure is using its SNA technology to mobilize the body's natural defense against cancer. The Company’s lead immunotherapy compound, AST-008 (initially being investigated in selected solid and hematological tumors) is a toll-like receptor 9 agonist. The design of it is to use the SNA's beneficial properties to drive a powerful anti-cancer immune response.

In September, Exicure announced Phase 1 results for AST-008, an SNA consisting of toll-like receptor 9 (TLR9) agonists designed for immuno-oncology applications. Dr. David Giljohann, Exicure’s Chief Executive Officer, said, “Phase 1 results for AST-008 demonstrated our desired highly potent immune system activation without serious adverse events or dose limiting toxicity. We believe this molecule could lead to better combination therapies for patients with cancer and, to that end, we expect to initiate a Phase 1b/2 trial in patients before year end.”

This month, Exicure announced that it presented pre-clinical data in a poster session at the 14th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) in Seattle, Washington from September 30-October 3, 2018. The first poster, authored and presented by Exicure scientists, titled “Spherical Nucleic Acids: Oral delivery and efficacy in TNBS-induced IBD model,” supports the local delivery benefits of the Company’s proprietary platform technology.

The second poster highlighted data generated by Regulus Therapeutics through a continuing scientific collaboration with Exicure. The poster, titled “Spherical Nucleic Acid (SNA) construct improves functional delivery of anti-microRNA oligonucleotide in pre-clinical studies in vitro and in vivo,” highlights improved delivery to the liver following systemic administration in mice. Additionally, it indicates the potential to broaden the application of Exicure’s proprietary SNA™ technology to miRNA targeting.

Exicure, Inc. (XCUR), closed Thursday's trading session at $3.84, down 2.78%, on 9,818 volume with 34 trades. The average volume for the last 3 months is 111,556 and the stock's 52-week low/high is $3.02/$6.50.


Innovus Pharmaceuticals, Inc. (INNV)

DSR News, Penny Stock Hub, PHUB News, Wall Street Mover, HotTopPennyStocks,, PennyPickAlerts, Fortune Stock Alerts, Penny Stock Bets, StockMister, 1-2-3 Stock Alerts, BUYINS.NET, Promotion Stock Secrets, TopPennyStockMovers, SeeThruEquityResearch, Penny Stock Circle, and OTPicks reported previously on Innovus Pharmaceuticals, Inc. (INNV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is a developing Over-The-Counter (OTC) consumer goods and specialty pharmaceutical company. It engages in the commercialization, licensing, and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. Innovus Pharmaceuticals is headquartered in San Diego, California.

The Company has plans to enter the oncology supportive care OTC market with an exclusive license to two GRAS (Generally Recognized As Safe by the U.S. FDA)-listed compounds, thymol and carvacrol, for cachexia and muscle growth and repair, from the University of Iowa Research Foundation. Innovus generates revenues from its lead products BTH® Testosterone Booster; BTH® Human Growth Agent; Zestra® for female arousal and EjectDelay® for premature ejaculation.

Innovus has an additional five marketed products. These include Sensum+® for the indication of decreased penile sensitivity; Zestra Glide®; Vesele® for promoting sexual health; RecalMax™ for promoting brain and cognitive health; Androferti® (in the U.S. and Canada) to support overall male reproductive health and sperm quality; BTH Vision Formula; BTH Blood Sugar, among others and eventually FlutiCare™ OTC for Allergic Rhinitis, if Innovus’ Abbreviated New Drug Application (ANDA) receives approval by the FDA.

Innovus Pharmaceuticals launched AllerVarx™ in the United States in 2017. AllerVarx™ is a clinically proven supplement, scientifically formulated for the relief of allergy symptoms. AllerVarx™, selling in Europe under the brand name Lertal®, is a product the Company exclusively in-licensed for the U.S. and Canada from NTC s.r.l. - an Italian company.

Last month, Innovus Pharmaceuticals announced that the FDA cleared the Company’s GlucoGorx™ Glucose Monitoring Test Kit that includes a glucose meter, test strips and lancet device (GlucoGorx™ Kit) under the 510(k) filing of its manufacturing partner, ACON Laboratories, Inc.

Innovus Pharmaceuticals will offer the GlucoGorx™ Kit, which will provide highly sensitive glucose level testing results within four seconds, to its customers who purchase its GlucoGorx™ clinical glucose supplement. The expectation is that Innovus will launch its GlucoGorx™ Kit and GlucoGorx™ in the second half of this year.

Last week, Innovus Pharmaceuticals announced the launch of its product Vesele®, approved by Health Canada for the increase in vasodilation via nitric oxide production, in Canada. Vesele® is available in Canada directly through Innovus’ website and through its Beyond Human™ marketing and sales platform.

Innovus Pharmaceuticals, Inc. (INNV), closed Thursday's trading session at $0.1098, up 3.58%, on 481,914 volume with 62 trades. The average volume for the last 3 months is 676,261 and the stock's 52-week low/high is $0.078/$0.209.


The Alkaline Water Company, Inc. (WTER)

StreetAuthority Financial, Penny Stock Rumble, InvestmentHouse, Investors Insights, MicroCap Gems, Investor Spec Sheet, Market FN, Wall Street Mover, SmallCapVoice, OTC Markets Group, Oakshire News Bulletin, and The Best Newsletters reported previously on The Alkaline Water Company, Inc. (WTER), and we also report on the Company, here at the QualityStocks Daily Newsletter.

The Alkaline Water Company, Inc. has developed an inventive, state-of-the-art, proprietary electrolysis beverage process. This process produces healthy alkaline water. The water is packaged and sold in 500ml, 700ml, 1-liter, 3-liter and 1 gallon sizes under the trade name Alkaline88®. Alkaline88's premier alkaline water is a pH balanced bottled alkaline drinking water enhanced with trace minerals and electrolytes. OTCQB-listed, The Alkaline Water Company is based in Scottsdale, Arizona.

At present, the Company packages and sells its alkaline water to over 40,000 retail locations in all 50 states. The design of Alkaline88 is to encourage daily consumption of Alkaline Water through a consumer-oriented bulk delivery system targeted at removing costly small bottles from the distribution supply chain. The production of Alkaline88 is at an 8.8 pH, intended to achieve optimal body balance.

The Alkaline Water Company incorporated 84 beneficial trace Himalayan minerals to make Alkaline88 especially unique to other pH waters. The Company employs an advanced Electrochemically Activated Water (ECA) system to create 8.8 pH drinking water without the use of any chemicals. The ECA process uses specialized electronic cells coated with an assortment of rare earth minerals to produce scientifically engineered water. Alkaline88® is now available at select retailers in a 1.5-liter bottle and a 1-liter 6-pack.

In April, The Alkaline Water Company announced that Raley’s (based in West Sacramento, California) is now selling Alkaline88® water in the 1-gallon and 3-liter sizes.

Mr. Richard A. Wright, President and Chief Executive Officer of the Alkaline Water Company, stated, “The record growth of Alkaline88® continues with the addition of Raley’s markets, number 45 on the Supermarket News list of 2018 top 75 retailers and wholesalers. We are currently in over 60 percent of the top 75 retailers and wholesalers and in over 40,000 retail locations nationwide. We are continuing to execute against plan and believe, by the end of fiscal year 2019, we will be in over 80 percent of the top retailers and 50,000 stores nationwide.”

In addition, in April, The Alkaline Water Company announced that record quarterly and monthly Sales were attained in their Q4 for the fiscal year ending March 31, 2018. Q4 Sales surpassed $6,000,000. Sales for the month of March 2018 topped $2,500,000. 

The Alkaline Water Company, Inc. (WTER), closed Thursday's trading session at $0.8571, up 3.25%, on 279,012 volume with 681 trades. The average volume for the last 3 months is 270,332 and the stock's 52-week low/high is $0.80/$3.45.


Thunder Energies Corporation (TNRG)

Penny Stock Hub, ResearchPool, Capital Cube, The Stock Radio, Marketbeat, WalletInvestor, InvestorPlace, The Silicon Review, InvestorsHub, Emerging Growth, Penny Stock Tweets, Morningstar, YCharts, The Street, Stockwatch and Market Exclusive reported on Thunder Energies Corporation (TNRG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Thunder Energies Corporation concentrates on the manufacture, sale, and service of diverse technologies in the United States. The Company previously went by the name Thunder Fusion Corporation. It changed its name to Thunder Energies Corporation in May 2014. Thunder Energies has its corporate office in Tarpon Springs, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Thunder Energies markets its technologies through three divisions. These are Optical Instruments, Nuclear Instruments, and Combustion Equipment.

Concerning the Division of Optical Equipment, its emphasis is the production, promotion, sale and service of pairs of Galileo telescopes with convex lenses to detect matter-galaxies & Santilli telescopes with concave lenses to detect antimatter-galaxies (international patent pending).

Regarding the Division of Nuclear Equipment, the production, promotion, sale and service of the Santilli Thermal Neutron Source is based on a novel synthesis of the neutron from a hydrogen gas (international patent pending). Concerning the Division of Combustion Equipment, its focus is the production, promotion, sale and service of the novel HyperFurnace, which achieves the total combustion of fossil fuels and an enhanced energy output (patented and international patents pending).

In May 2018, Dr. Ruggero M. Santilli, Chief Executive Officer and Chief Scientist of Thunder Energies announced new advances for the model of Directional Neutron Source developed in the United States and tested in nuclear facilities in Europe for the detection in airports of nuclear material that may be concealed in suitcases, the detection and concentration of precious metals in mining operations, different military uses, and other applications.

This month, Dr. Ruggero M. Santilli, Chairman of the Board of Thunder Energies Corporation announced the appointment of Mr. T. Scott Wainwright, as President of the Company. Dr Santilli stated, “I first met Mr. Wainwright in 2010 when, as CEO of Magnegas Corporation, I hired him as President of the company and Director of Sales. He was able to expand the sales territory by building a successful sales force and adding large accounts. In addition, Mr. Wainwright distinguished himself as part of the team that uplisted Magnegas Corporation to the Nasdaq market with a capital raise of $4,000,000. I am pleased that he accepted the offer to join our team as president of Thunder Energies Corporation at this important time in the development of our company.”

Thunder Energies Corporation (TNRG), closed Thursday's trading session at $0.00649, down 12.30%, on 7,501,832 volume with 68 trades. The average volume for the last 3 months is 902,366 and the stock's 52-week low/high is $0.0057/$0.30.


Mentor Capital, Inc. (MNTR)

Promotion Stock Secrets, InvestorsUnderground, Cancer Roll Up Strategy, Stockgoodies, Laissez Faire Today, BUYINS.NET, Stocks That Move, Wealth Insider Alert, Market Intelligence Center Alert, StreetAuthority Daily, Five Star Stock Picks, and Stock Profile reported on Mentor Capital, Inc. (MNTR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Mentor Capital, Inc. provides mezzanine financing to leaders in the cannabis space. The Company looks to come alongside and assist larger private medical marijuana and cannabis companies and their founders in meeting their liquidity, and financial goals, to add protection for investors, and to help incubate private cannabis companies. Mentor Capital has its headquarters in San Diego, California. The Company lists on the OTC Markets Group’s OTCQB.

Mentor’s preferred involvement is with larger and private pre-IPO (Initial Public Offering) medical marijuana companies that it can help operationally prepare for the public market and finance, sometimes working with institutional partners looking for public liquidity. Mentor Capital transferred to the cannabis space from front-line cancer investments.

Mentor Capital takes a major position in the diverse members of its portfolio of participating companies. Nonetheless, it leaves operating control in the hands of the cannabis company founders.

Mentor participates in the legal recreational marijuana market. However, its favored focus is medical. The Company looks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing ocular pressures from glaucoma, in addition to blunting chronic pain.

Mentor Capital announced this past February that it extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Mentor Capital stated it would be pleased to make a series of cannabis focused investments with cannabis veteran and Pueblo Founder, Pat Leonard.

Mentor Capital has set up Mentor Partner II, LLC as a channel for this purpose. The initial investment is about $400,000 lease of a system for supercritical extraction.

This week, Mentor Capital announced that it filed its quarterly 10-Q filing for Q1 ended March 31, 2018, with the Securities and Exchange Commission (SEC). For the quarter ended March 31, 2018, the Company had Revenues of $1,016,199 and Gross Profit of $345,707 with a resulting Net Loss Attributable to Mentor Capital of ($151,704) or (0.7 cents) per share.

This represents an improvement in Revenue from the previous year quarter ended March 31, 2017 Revenues of $738,144 and Gross Profit of $263,896. The Net Loss attributable to Mentor Capital for the year ago quarter ended March 31, 2017 was ($460,176) or (0.21 cents) per share.

Mentor Capital, Inc. (MNTR), closed Thursday's trading session at $0.74, up 13.85%, on 104,313 volume with 80 trades. The average volume for the last 3 months is 83,100 and the stock's 52-week low/high is $0.642/$2.65.


EnviroLeach Technologies, Inc. (EVLLF)

Dividend Investor, Marketwired, Streetwise Reports MarketWatch, Stockhouse, GuruFocus, 4-Traders, OTC Markets, Barchart, Investopedia, Investors Hub, and Stock Market Revolution reported on EnviroLeach Technologies, Inc. (EVLLF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Established in 2016, EnviroLeach Technologies, Inc. is a technology enterprise and near-term gold producer. The Company engages in the development and commercialization of environmentally-friendly formulas and technologies for the treatment of materials in the mining and E-Waste sectors. Its aim is to become a foremost gold producer through the “Urban-Mining” of end-of-life electronics and be a major player in the extraction of precious metals in the traditional mining space. EnviroLeach Technologies has its headquarters in Burnaby, British Columbia.

Utilizing its proprietary non-cyanide, non-acid based process, EnviroLeach extracts precious and base metals from ores, concentrates, and E-Waste using only Food and Drug Administration (FDA) approved additives. The Company developed an inventive, cost-effective and environmentally-friendly alternative to cyanide and strong-acid based processes currently used for the extraction of precious metals from mineral ores, concentrates and E-Waste.

The process is alike to the standard cyanide vat leaching circuits used today. However, it is much safer and simpler. The patent-pending EnviroLeach formula consists of combining five non-toxic, FDA approved dry ingredients with ambient temperature water.

EnviroLeach Technologies and Mineworx Technologies successfully advanced their proven chemical formulas and mechanical processes last year with several additional proprietary and patent-pending breakthroughs. The new discoveries include significant enhancements to the proven EnviroLeach E-Waste process concerning improved leach kinetics, improved recoveries, metal complex stability, element selectivity, metal precipitation and the reusability of the primary solution.

The two companies also completed a series of successful pilot scale tests throughout 2017. They completed the design, engineering and construction of the first production scale, 10 tonne per day E-Waste processing plant, which was installed on-schedule and on-budget at the Memphis, Tennessee facility.

The EnviroLeach reagent is well suited for the leaching of gold in an agitated or vat leach type process. This includes the treatment of whole ores, gravity concentrates, flotation concentrates, as well as E-Waste. This segment of the market represents most of the global gold produced.

The Company states that the EnviroLeach process could be an effective alternative for many potentially economic gold deposits that are unable to secure permitting due to cyanide restrictions.

EnviroLeach Technologies, Inc. (EVLLF), closed Thursday's trading session at $0.80, up 3.65%, on 100 volume with 1 trade. The average volume for the last 3 months is 22,693 and the stock's 52-week low/high is $0.4783/$1.855.


Bespoke Extracts, Inc. (BSPK)

Ventureline, Stockopedia, Investors Hangout, Wallet Investor, Infront Analytics, YCharts, Morningstar, Market Exclusive, Simply Wall St, Stockhouse, Marketwired, MarketWatch, and Wallmine reported earlier on Bespoke Extracts, Inc. (BSPK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bespoke Extracts, Inc. is a producer of high quality, flavorful, hemp-derived cannabidiol (CBD) extract products. The Company established in early 2017 to introduce a proprietary line of premium quality, all-natural CBD products in the form of tinctures and capsules for the nutraceutical and veterinary markets. OTCQB-listed, Bespoke Extracts is headquartered in Sunny Isles Beach, Florida.

Bespoke’s products are produced using pure, all natural, zero-THC phytocannabinoid-rich (PCR) hemp-derived CBD. CBD is non-psychoactive. The Company’s products are marketed as dietary supplements and distributed through Bespoke’s direct-to-consumers ecommerce store.

The Company strives to use only vegan, Fair Trade Certified, and organic ingredients with fast acting benefits for anyone looking for an alternative remedy. Bespoke Extracts’ focus is on premium ingredients. The Company’s farmers have been innovators in hemp agriculture, farming practices, agrotech, and production for generations. Bespoke’s hemp is stable, high in CBD, low in THC, and resistant to pathogens and pests.

The Company’s products include Sport Lemon Lime Tincture – THC Free 1500MG; CBD Manuka Honey Tincture; and CBD Bacon Flavored Pet Tincture. In addition, products include CBD Softgel Capsules; CBD Pain Relief Cream; and CBD Isolate Powder.

Bespoke Extracts announced in July 2018 that it signed an agreement with Seidman Food Brokerage (SFB), providing for SFB to market Bespoke Extract’s proprietary CBD tinctures, lotions, and salves to greater than 1,500 stores located in Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, The Bahamas and Puerto Rico.

Last month, Bespoke Extracts announced that Grammy-nominated, American Hip Hop superstar Soulja Boy Tell Em (Soulja Boy) signed a deal with the Company to collaborate on the development of a co-branded line of high quality CBD products. Soulja Boy will also proactively market and publicly endorse Bespoke Extracts’ complete proprietary line of CBD products to his huge social media fan base.

This week, Bespoke Extracts congratulated Hairy Kiwi/Bespoke CBD-sponsored rookie Mr. Sean Dylan Kelly for winning the 35th Annual Race of Champions in his debut appearance at Daytona International Speedway. Mr. Kelly lapped the second finisher.

Mr. Kelly said, "Thanks to Bespoke CBD’s sponsorship and Robertino Pietri and EJ Viso for all the coaching and support, I was given the opportunity to win one of the most prestigious motorcycle races on the planet.  I’m very grateful.” 

Bespoke Extracts, Inc. (BSPK), closed Thursday's trading session at $0.15, up 7.14%, on 23,349 volume with 11 trades. The average volume for the last 3 months is 338,092 and the stock's 52-week low/high is $0.105/$3.00.


The QualityStocks Company Corner

Victory Marine Holdings Corp. (VMHG)

The QualityStocks Daily Newsletter would like to spotlight Victory Marine Holdings Corp. (VMHG).

NetworkNewsAudio announces the Audio Press Release (APR) titled “Rising Global Economic Tide Lifts Yacht and Boat Firms High,” featuring Victory Marine Holdings Corp. (OTC: VMHG). To hear the NetworkNewsAudio version, visit: To read the full editorial, visit:

Victory Marine Holdings Corp. (VMHG) is a world-class yacht sales, brokerage and consulting firm with a sprawling inventory of new and used boats, financing, insurance, documentation and recreational marine accessories. Located in Miami, Florida – the “yacht capital of the world” – Victory Marine has over 20 years of experience in an industry hailed as “an American pastime and economic engine” by the National Marine Manufacturers Association (“NMMA”).

According to the NMMA, marine sales reached $39 billion in 2017. To capture its share of this market, Victory Marine has established partnerships with several selective manufacturers and is pursuing opportunities for vertical growth. While the company’s near-term focus is on expansion of its inventory and sales team, its longer-term plans reflect the current state of the broader yacht industry.

Marine sales are at a 10-year high, and though yacht manufacturers are operating at full capacity, delivery of some products can take longer than 18 months. As a result, Victory Marine is taking steps to establish its own pipeline. Management is currently in negotiations with several yacht manufacturers to build the company its own unique, private-label design, which would enable Victory Marine to quickly deliver a superior product to its clients.

Demand for recreational boat trailers is also on the rise, with growth reported for nearly all powerboat segments. Florida continues to ride the top of that crest with sales of powerboats, trailers, and accessories up 10 percent in 2017 to $2.9 billion, followed by Texas ($1.7 billion) and Michigan ($982 million).

Victory Marine’s wholly owned Excalibur Trailers USA subsidiary is set to take advantage of this market, and is approved by the Society of Automotive Engineers (SAE International) to build custom marine aluminum trailers for recreational boats, as well as for commercial boat transport. Excalibur Trailers USA has filed the necessary paperwork to trademark its brand name and logo and is seeking a suitable manufacturing facility in South Florida for production of powerboat, sailboat, catamaran, powerboat and Jet Ski trailers.

Leading Victory Marine to capture its share of the market is company CEO Orlando Hernandez, whose experience in the marine industry includes negotiation, business planning, investor relations, operations management and sales. He is joined by veteran yacht broker Gary Beaver, who has more than 20 years of successful yacht sales and industry experience. Beaver brings to Victory Marine his portfolio of approximately 25 vessel listings, valued in excess of $10 million.

Victory Marine Holdings Corp. (VMHG), closed the day's trading session at $0.0999, up 11.12%, on 37,360 volume with 12 trades. The average volume for the last 3 months is 52,805 and the stock's 52-week low/high is $0.0655/$0.97.

Recent News


Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Texas-based Sharing Services (OTCQB: SHRV) is a diversified holding company operating in the direct selling industry. To view the full article, visit:

Sharing Services, Inc. (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.22, up 10.00%, on 3,700 volume with 3 trades. The average volume for the last 3 months is 12,483 and the stock's 52-week low/high is $0.125/$0.59.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) and its wholly-owned subsidiary, TGOD Acquisition Corporation ("SpinCo"), are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") pursuant to which the Company will, subject to the terms and conditions of the Arrangement Agreement, effect the previously announced spin-off transaction (the "Spin-Off") whereby TGOD will distribute to TGOD shareholders (the "Distribution") unit purchase warrants of SpinCo (the "SpinCo Unit Warrants") by way of a court-approved plan of arrangement (the "Arrangement").

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.03763, up 6.58%, on 964,934 volume with 1,973 trades. The average volume for the last 3 months is 1,164,996 and the stock's 52-week low/high is $2.68/$7.89.

Recent News


Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Standard Lithium Ltd. (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L), is pleased to announce that the Company has completed the construction of the prototype pilot plant for its proprietary selective crystallisation process, and is currently commissioning the plant for operation.  The pilot prototype has been designed and fabricated in partnership with Saltworks Technologies Inc. and will be initially operated at their facility in Richmond, British Columbia, Canada.

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.


Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $1.0603, up 5.49%, on 34,743 volume with 32 trades. The average volume for the last 3 months is 49,670 and the stock's 52-week low/high is $0.604/$2.23.

Recent News


Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

A growing market is supporting a wave of acquisitions and cross-company investments in the cannabis industry. One of the companies making a pick-and-shovel play is Sugarmade, Inc. (OTCQB: SGMD), which is expanding its position in cultivation supplies through acquisitions and marketing agreements.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include:;; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.


CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1181, up 2.70%, on 1,894,921 volume with 205 trades. The average volume for the last 3 months is 2,305,023 and the stock's 52-week low/high is $0.0309/$0.43.

Recent News


Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was highlighted today in a report examining a new opinion poll in North Dakota suggesting that those in favor of legalizing recreational marijuana will take the day when the matter is voted upon during the midterm polls next month. This ballot measure comes after the state legalized medical marijuana two years ago and implementation is set to start next year.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $7.73, even for the day, on 208,200 volume with 939 trades. The average volume for the last 3 months is 467,125 and the stock's 52-week low/high is $3.167/$16.25.

Recent News


VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was highlighted today in a report examining a new opinion poll in North Dakota suggesting that those in favor of legalizing recreational marijuana will take the day when the matter is voted upon during the midterm polls next month. This ballot measure comes after the state legalized medical marijuana two years ago and implementation is set to start next year.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.81, up 1.94%, on 260,363 volume with 239 trades. The average volume for the last 3 months is 594,890 and the stock's 52-week low/high is $0.682/$3.293.

Recent News


CytoDyn Inc. (CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) is focused on providing real hope and help to the millions of people infected with the human immunodeficiency virus (HIV) and those suffering from several devastating forms of cancer. The company’s lead product candidate, PRO 140 (leronlimab), is in advanced stages of clinical development as a therapy for HIV/AIDS, and plans to expand investigations with PRO 140 into cancer are underway. Nader Pourhassan, Ph.D., president and CEO of CytoDyn, updated shareholders during a recent conference call that was highlighted in a corporate summary from leading independent small cap media portal (

CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.52, off by 0.47%, on 162,425 volume with 35 trades. The average volume for the last 3 months is 246,826 and the stock's 52-week low/high is $0.40/$0.836.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Marijuana Company of America, Inc. (OTC: MCOA), a client of CNW that focuses on product research and development of legal hemp-based consumer products containing CBD under the brand name "hempSMART," an affiliate marketing program to promote and sell its legal hemp-based consumer products, leasing of real property, and the expansion of its business into ancillary areas of the legalized cannabis and hemp industry. To view the full publication, titled “Changing Attitudes in Washington Offer Promise for Hemp and Cannabis Market,” visit:

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0207, even for the day, on 9,435,459 volume with 342 trades. The average volume for the last 3 months is 8,853,407 and the stock's 52-week low/high is $0.02/$0.073.

Recent News


BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

The battle against breast cancer is taking a technological turn amid an increasing drive to develop therapies that use the body’s own immune system to destroy life-threatening cancer cells. BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) is on the front line of the battle and is currently testing its immuno-oncology biotechnology in phase I and IIa trials involving advanced-stage breast cancer patients.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.083, off by 2.35%, on 47,000 volume with 3 trades. The average volume for the last 3 months is 15,686 and the stock's 52-week low/high is $0.068/$0.139.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Mineral explorer Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) continues to announce encouraging news from its drilling program at the company’s wholly owned Ollague Project in Chile. The drilling program confirms the reliability of TEM geophysical profiles in identifying lithium-bearing brine carrying highly conductive zones and suggests that lithium grades increase with depth, according to a recent news release (

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.471, off by 2.08%, on 40,060 volume with 16 trades. The average volume for the last 3 months is 50,358 and the stock's 52-week low/high is $0.4235/$0.97.

Recent News


Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis industry incubator Cannabis Strategic Ventures, Inc. (OTC: NUGS) is working its way toward a national stock exchange uplisting and growing its presence within the industry through a series of timely business building ventures, including the introduction of PureOrganix, a brand marketed by subsidiary Pure Applied Sciences as a California dispensary shelf item that expects to blossom in a ready national and international market for legalized plant products.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $3.085, off by 6.23%, on 30,461 volume with 87 trades. The average volume for the last 3 months is 106,113 and the stock's 52-week low/high is $0.031/$7.13.

Recent News



The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Cannabis Stocks Defy Gravity During Market Plunge,” featuring NUGL, Inc. (OTC: NUGL). To hear the CannabisNewsAudio version, visit: To read the full editorial, visit:

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.98, off by 4.35%, on 275,897 volume with 387 trades. The average volume for the last 3 months is 195,510 and the stock's 52-week low/high is $0.405/$2.64.

Recent News


RYU Apparel, Inc. (TSX.V: RYU) (OTC: RYPPF) (FRA: RYA)

The QualityStocks Daily Newsletter would like to spotlight RYU Apparel, Inc. (RYPPF).

RYU Apparel Inc. (TSX VENTURE: RYU.V, OTCQB: RYPPF), creators of urban athletic apparel, is pleased to announce the official opening of its community space in the basement of its 361 Queen Street West retail location in Toronto. The space has been named "RYU UNDERGROUND" and will serve as a hub for community workouts, functions relating to health and fitness and generally as a venue for the RYU community to meet and connect. Also today, the company was highlighted in an article discussing how a new generation of urban fashion disruptors is continuing to steal market share from major brands, riding the athleisure trend to define new market segments.

Engineered for the fitness, performance and lifestyle of the athletically-minded, RYU Apparel, Inc. (DBA RYU \ Respect Your Universe) (TSX-V: RYU) (OTC: RYPPF) (FRA: RYA) develops, markets and distributes apparel, bags and accessories for active people living their lives with integrity. Headquartered in Vancouver, Canada, with with four stores located in Greater Vancouver Area, British Columbia and one in Toronto, RYU opened its first U.S.-based store at the iconic Abbot Kinney Boulevard in Venice California, on August 2, 2018. Additional retail locations are slated to open soon in Etokicoke, Ontario, Canada; Brooklyn, New York; and Newport Beach, California, with plans to establish nearly two dozen more store locations by the end of 2022.

Respect Your Universe’s award-winning brand celebrates, encourages and respects an individual’s choices and journey in life, promoting a fitness lifestyle culture. Innovatively designed without compromise and tailored for fit, comfort and durability, RYU exists to facilitate human performance. RYU’s urban athletic apparel and accessories product line has been featured by some of the most influential fitness and outdoor lifestyle publications and social media connectors.

The company recently was honored in Madrid, Spain, as a 2018 Finalist in the World Retail Awards in the categories of “Retail Start Up of the Year” and “Social Media Campaign of the Year,” (#RYUOneMoreRep). RYU is one of only two Canadian companies that qualified as finalists among many global retailers across all categories of the World Retail Awards annual event. The World Retail Awards have been recognizing the very best retailers and retail initiatives across a range of categories since 2007.

Marcello Leone, CEO of RYU, said the company’s inclusion in the prestigious lineup of finalists was gratifying, stating, “Being chosen by the World Retail Awards is a fantastic accolade. We are proud to be among a group of global peers that are considered to become the next generation of iconic brands. #RYUOneMoreRep Media Campaign is also another confirmation of the social aspect that permeates our brand and the impact we are having in our community.”

In addition to its retail locations, RYU generates sales through its e-commerce platform and has developed strategic relationships with companies such as Global-E, Netamorphosis, Fancy and the NHL Vancouver Canucks to expand its reach. RYU is also building connections with influential leaders and social media influencers who represent the company’s values of aliveness, bold expression, curiosity, discipline and respect. Under RYU’s Connector Program, each leader actively engages in community charities, volunteer efforts and participates in charity programs. Among the famous personalities and community leaders connecting with the RYU brand are:

  • Alexandra Ianculescu, a Canadian National Team Olympic Speed Skater
  • Ben Carr, professional trainer
  • Tori Katongo, personal trainer, singer, actor, dancer
  • Simon “Thor” Damborg, head coach at Raincity Athletics
  • Cassie Hawrysh, a Canadian National Team Skeleton Racer
  • Dai Manuel, lifestyle mentor and author of “The WholeLife Manifesto”

Company CEO Leon is the founder of Naturo Group Investment Inc., a company that sells nutritional beverages, and also is the former VP of operations and president of LEONE, an independent high fashion specialty store in Vancouver, Canada. Chief Financial Officer Pedro Villa is a certified CPA who has held several senior positions in various North American companies. Brett Pawson, senior VP of retail and operations, has more than 15 years of experience in sales and operations in the wellness, consumer goods and retail sectors.

RYU’s strategic focus is on becoming a global leader as a fitness and training apparel and accessories brand for athletes in multiple disciplines. RYU’s goal is to facilitate human performance by honoring and celebrating the extraordinary oneness of humanity by respecting each other’s differences – Respect Your Universe.

RYU Apparel, Inc. (RYPPF), closed the day's trading session at $0.125, off by 8.96%, on 165,030 volume with 50 trades. The average volume for the last 3 months is 107,316 and the stock's 52-week low/high is $0.05/$0.255.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.